Skip to main content
. 2022 Jan 12;12:722349. doi: 10.3389/fimmu.2021.722349

Table 1.

Patients’ demographic. Age, Gender, CRP, VAS, serology and detail on treatment. Healthy control (HC) demographic, age and gender.

Parameters HC (n=ll') RA (n=&Z) PsA (fn=37) OA (n-6)
Age (Mean ± SD) 33±10 55±13.6 51±11.9 67±8
Gender
Female 78% 68% 65% 33%
Male 22% 32% 38% 67%
CRP 14+14.1 8+9.3 3.3+3.2
VAS 52±30 49±25 50±10
ACPA
POS 60% 0% 0%
NEG 40% 100% 100%
RF
POS 65% 0% 0%
NEG 35% 100% 100%
Treatments
No Medication 27% 35% 100%
Methotrexate
alone
10% 19% 0%
MTX in
ombination
19% 11% 0%
Anti-TNF 3% 5% 0%
Biological 10% 16% 0%
Others 31% 14% 0%